MEDICUS PHARMA LTD. (MDCX)
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
SIGNING DAY SPORTS, INC. COMMON STOCK (SGN)
Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule
JIUZI HOLDINGS, INC. (JZXN)
Jiuzi Holdings and AetheriumX Sign Strategic MOU for $30M Investment into Web3
AMERICAN INTEGRITY INSURANCE GROUP, INC. COMMON STOCK (AII)
Almonty Completes Phase 1 of Sangdong Tungsten Mine in South Korea
ANNOVIS BIO, INC. (ANVS)
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
AGENUS INC. (AGEN)
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
ZEVRA THERAPEUTICS, INC. (ZVRA)
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
BIOSIG TECHNOLOGIES, INC. (STEX)
Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer
SIRIUSPOINT LTD. (SPNT)
SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions
FERGUSON ENTERPRISES INC. (FERG)
Ferguson Files Definitive Proxy Materials and Transition Report
QUIPT HOME MEDICAL CORP. (QIPT)
Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager
FERGUSON ENTERPRISES INC. (FERG)
Ferguson Files Definitive Proxy Materials and Transition Report
FLOWSERVE CORPORATION (FLS)
Flowserve Appoints Brian Savoy to Board of Directors
V2X, INC. (VVX)
V2X and Elastic Partner to Strengthen Search and Agentic Analytics Across Government Mission Workflows
PALVELLA THERAPEUTICS, INC. (PVLA)
Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin